Found: 168
Select item for more details and to access through your institution.
How to customize common data models for rare diseases: an OMOP-based implementation and lessons learned.
- Published in:
- Orphanet Journal of Rare Diseases, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13023-024-03312-9
- By:
- Publication type:
- Article
Precision Culture Scaling to Establish High‐Throughput Vasculogenesis Models.
- Published in:
- Advanced Healthcare Materials, 2024, v. 13, n. 18, p. 1, doi. 10.1002/adhm.202400388
- By:
- Publication type:
- Article
Precision Culture Scaling to Establish High‐Throughput Vasculogenesis Models (Adv. Healthcare Mater. 18/2024).
- Published in:
- Advanced Healthcare Materials, 2024, v. 13, n. 18, p. 1, doi. 10.1002/adhm.202470114
- By:
- Publication type:
- Article
Successful treatment of scleromyxoedema with daratumumab.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 9, doi. 10.1111/bjh.19366
- By:
- Publication type:
- Article
Gemtuzumab ozogamicin plus midostaurin in combination with standard '7 + 3' induction therapy in newly diagnosed AML: Results from the SAL‐MODULE phase I study.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2254, doi. 10.1111/bjh.19436
- By:
- Publication type:
- Article
Cyclosporin A-Based PROTACs Can Deplete Abundant Cellular Cyclophilin A without Suppressing T Cell Activation.
- Published in:
- Molecules, 2024, v. 29, n. 12, p. 2779, doi. 10.3390/molecules29122779
- By:
- Publication type:
- Article
Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01060-4
- By:
- Publication type:
- Article
Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence.
- Published in:
- NPJ Digital Medicine, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s41746-024-01076-x
- By:
- Publication type:
- Article
VEXAS syndrome: complete molecular remission after hypomethylating therapy.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 3, p. 993, doi. 10.1007/s00277-023-05611-w
- By:
- Publication type:
- Article
CD38 promotes hematopoietic stem cell dormancy.
- Published in:
- PLoS Biology, 2024, v. 22, n. 2, p. 1, doi. 10.1371/journal.pbio.3002517
- By:
- Publication type:
- Article
Ten simple rules for designing graphical abstracts.
- Published in:
- PLoS Computational Biology, 2024, v. 20, n. 2, p. 1, doi. 10.1371/journal.pcbi.1011789
- By:
- Publication type:
- Article
Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8<sup>+</sup> clonal effector and CAR T-cell function while promoting a senescence-associated phenotype.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 1, p. 1, doi. 10.1007/s00262-023-03594-1
- By:
- Publication type:
- Article
M‐CSF directs myeloid and NK cell differentiation to protect from CMV after hematopoietic cell transplantation.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 11, p. 1, doi. 10.15252/emmm.202317694
- By:
- Publication type:
- Article
Steady‐state versus chemotherapy‐based hematopoietic cell mobilization after anti‐CD38‐based induction therapy in newly diagnosed multiple myeloma.
- Published in:
- Transfusion, 2023, v. 63, n. 11, p. 2131, doi. 10.1111/trf.17566
- By:
- Publication type:
- Article
Working situation and burden of work limitations in sarcoma patients: results from the multi-center prospective PROSa study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6009, doi. 10.1007/s00432-022-04556-3
- By:
- Publication type:
- Article
Editorial: Deciphering the bone marrow microenvironment in hematologic malignancies.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1231467
- By:
- Publication type:
- Article
Outcomes after allogeneic haematopoietic stem cell transplantation in young adults in Germany.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 308, doi. 10.1111/bjh.18610
- By:
- Publication type:
- Article
Non-viral TRAC-knocked-in CD19<sup>KI</sup>CAR-T and gp350<sup>KI</sup>CAR-T cells tested against Burkitt lymphomas with type 1 or 2 EBV infection: In vivo cellular dynamics and potency.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1086433
- By:
- Publication type:
- Article
Study protocol: the OptiScreen-Study: optimized psycho-oncological care—from screening to intervention.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1343, doi. 10.1007/s00432-022-04368-5
- By:
- Publication type:
- Article
Mesenchymal stromal cell-associated migrasomes: a new source of chemoattractant for cells of hematopoietic origin.
- Published in:
- Cell Communication & Signaling, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12964-022-01028-6
- By:
- Publication type:
- Article
Medical microrobots in reproductive medicine from the bench to the clinic.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36215-7
- By:
- Publication type:
- Article
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 913, doi. 10.1007/s00432-022-04407-1
- By:
- Publication type:
- Article
Correction: Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow‑up of 14.4 years.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Successful Combination of Olaparib and <sup>225</sup>Ac-Dotatate in a Patient with Neuroendocrine Tumor G3 and BRCA Mutation.
- Published in:
- Case Reports in Oncology, 2023, v. 16, n. 1, p. 1166, doi. 10.1159/000533198
- By:
- Publication type:
- Article
Combining Cryogel Architecture and Macromolecular Crowding‐Enhanced Extracellular Matrix Cues to Mimic the Bone Marrow Niche.
- Published in:
- Macromolecular Chemistry & Physics, 2023, v. 224, n. 1, p. 1, doi. 10.1002/macp.202200348
- By:
- Publication type:
- Article
Combining Cryogel Architecture and Macromolecular Crowding‐Enhanced Extracellular Matrix Cues to Mimic the Bone Marrow Niche.
- Published in:
- Macromolecular Chemistry & Physics, 2023, v. 224, n. 1, p. 1, doi. 10.1002/macp.202200348
- By:
- Publication type:
- Article
Fascia training in patients undergoing allogeneic hematopoietic cell transplantation—a pilot study.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 1, p. 1, doi. 10.1007/s00520-022-07529-x
- By:
- Publication type:
- Article
Klonale Hämatopoese – Bedeutung für die Zelltherapie.
- Published in:
- Der Internist, 2022, v. 63, n. 11, p. 1126, doi. 10.1007/s00108-022-01403-y
- By:
- Publication type:
- Article
Distress in soft-tissue sarcoma and gastrointestinal stromal tumours patients-Results of a German multicentre observational study (PROSa).
- Published in:
- Psycho-Oncology, 2022, v. 31, n. 10, p. 1700, doi. 10.1002/pon.6009
- By:
- Publication type:
- Article
Bone marrow mesenchymal stromal cell-derived extracellular matrix displays altered glycosaminoglycan structure and impaired functionality in Myelodysplastic Syndromes.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.961473
- By:
- Publication type:
- Article
Semi-supervised learning in cancer diagnostics.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.960984
- By:
- Publication type:
- Article
The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients-results of a Nationwide Observational Study (PROSa).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Predicting unplanned hospital readmission in palliative outpatients (PRePP) – study protocol of a longitudinal, prospective study to identify informal caregiver-related and structural predictors.
- Published in:
- BMC Palliative Care, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12904-022-00955-y
- By:
- Publication type:
- Article
RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with DNMT3A Mutations.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 5, p. 854, doi. 10.3390/cells11050854
- By:
- Publication type:
- Article
Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 5, p. 1171, doi. 10.1007/s00432-021-03702-7
- By:
- Publication type:
- Article
A Self‐Assembled Matrix System for Cell‐Bioengineering Applications in Different Dimensions, Scales, and Geometries.
- Published in:
- Small, 2022, v. 18, n. 13, p. 1, doi. 10.1002/smll.202104758
- By:
- Publication type:
- Article
Point Mutations in the FLT3 -ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A -PTD.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.862991
- By:
- Publication type:
- Article
Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Analysis of Subset Chimerism for MRD-Detection and Pre-Emptive Treatment in AML.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.841608
- By:
- Publication type:
- Article
Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse.
- Published in:
- Cancer Management & Research, 2022, v. 14, p. 547, doi. 10.2147/CMAR.S339846
- By:
- Publication type:
- Article
Machine learning assisted real-time deformability cytometry of CD34+ cells allows to identify patients with myelodysplastic syndromes.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-04939-z
- By:
- Publication type:
- Article
Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer.
- Published in:
- Frontiers in Genetics, 2022, v. 12, p. 1, doi. 10.3389/fgene.2021.811291
- By:
- Publication type:
- Article
Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 1, p. 41, doi. 10.1007/s00280-021-04361-8
- By:
- Publication type:
- Article
Financial toxicity in sarcoma patients and survivors in Germany: results from the multicenter PROSa study.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 1, p. 187, doi. 10.1007/s00520-021-06406-3
- By:
- Publication type:
- Article
Spatial heterogeneity and differential treatment response of acute myeloid leukemia and relapsed/refractory extramedullary disease after allogeneic hematopoietic cell transplantation.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221115005
- By:
- Publication type:
- Article
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221090882
- By:
- Publication type:
- Article
Long-Term Mixed Chimerism After Ex Vivo / In Vivo T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.776946
- By:
- Publication type:
- Article
Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross‐sectional results of a German multicentre observational study (PROSa).
- Published in:
- European Journal of Cancer Care, 2021, v. 30, n. 6, p. 1, doi. 10.1111/ecc.13484
- By:
- Publication type:
- Article
Myelodysplastic Syndromes and Metabolism.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 20, p. 11250, doi. 10.3390/ijms222011250
- By:
- Publication type:
- Article
P-175: Outcomes of autologous-allogeneic vs autologous tandem approach followed by thalidomide maintenance for transplant-eligible patients with newly diagnosed multiple myeloma: a prospective phase II-study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S132, doi. 10.1016/S2152-2650(21)02302-8
- By:
- Publication type:
- Article